BMJ  2004;329:232 (24 July), doi:10.1136/bmj.329.7459.232-b

Letter

Monitoring procalcitonin is of value in acute pancreatitis

The first 150 words of the full text of this article appear below.

EDITOR—In their discussion of the important issue of antibiotic prophylaxis in acute pancreatitis, I was surprised that O'Reilly and Kingsnorth made no mention of monitoring the plasma concentration of procalcitonin.1 A considerable literature now exists, establishing the value of procalcitonin monitoring in acute pancreatitis,2-4 and it is our practice to use the APACHE II score and the value of this inflammatory marker to guide the requirement for early antibiotic prophylaxis with a carbipenem and fluconazole.

A recent study has shown that the plasma concentration of procalcitonin may reflect the derangement in gut barrier function (rather than the extent of systemic inflammation) and may hence predict those patients in whom the translocation of bacteria and fungi into dead pancreas is more likely.5

I agree with the authors that we do not want to give all patients with acute pancreatitis antibiotic prophylaxis. But I have experience of fatal acute pancreatitis . . . [Full text of this article]

David Bihari, associate professor

University of New South Wales Lismore Base Hospital, Lismore, NSW 2480, Australia biharid@aol.com


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Management of acute pancreatitis
Derek A O'Reilly and Andrew N Kingsnorth
BMJ 2004 328: 968-969. [Extract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ